According to SEC filings for the period ending December 2025, Summit Therapeutics Inc. (NASDAQ:SMMT) is held by 197 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 36,391,063 | 2,668,089 | 7.91% | $636,479,692.00 |
| FMR LLC | 31 Dec, 2025 | 13,360,807 | 4,442,920 | 49.82% | $233,680,513.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 11,177,220 | -202,508 | -1.78% | $195,489,577.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 9,361,921 | 1,998,128 | 27.13% | $163,739,998.00 |
| STATE STREET CORP | 31 Dec, 2025 | 6,636,361 | 274,425 | 4.31% | $116,069,954.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 3,147,480 | 14,745 | 0.47% | $55,063,414.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 2,475,708 | 2,272,996 | 1,121.29% | $43,300,133.00 |
| Polymer Capital Management (HK) LTD | 31 Dec, 2025 | 1,421,155 | 603,879 | 73.89% | $24,856,001.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 1,383,775 | -220,388 | -13.74% | $24,381,751.00 |
| NORGES BANK | 31 Dec, 2025 | 1,373,943 | 1,373,943 | 0.00% | $24,030,263.00 |
| APEIRON CAPITAL Ltd | 31 Dec, 2025 | 1,309,241 | -1,700 | -0.13% | $22,898,625.00 |
| TD ASSET MANAGEMENT INC | 31 Dec, 2025 | 1,205,272 | 667,742 | 124.22% | $21,080,207.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 927,171 | -212,359 | -18.64% | $16,216,221.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 926,579 | -1,000,249 | -51.91% | $16,205,867.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 892,629 | 16,239 | 1.85% | $15,612,081.00 |
| UBS Group AG | 31 Dec, 2025 | 870,719 | -408,064 | -31.91% | $15,228,875.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 715,410 | -295,616 | -29.24% | $12,512,521.00 |
| Rock Springs Capital Management LP | 31 Dec, 2025 | 710,000 | 0 | 0.00% | $12,417,900.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 578,248 | 553,218 | 2,210.22% | $10,113,558.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 554,300 | -229,900 | -29.32% | $9,694,707.00 |